Fifth Third Bancorp
MDCO

Fifth Third Bancorp’s Medicines Co MDCO Stock Holding History

Fifth Third Bancorp’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-650
Closed -$25K – 2341
2017
Q2 		$25K Buy
+650
New +$28.9K ﹤0.01% 1494
2016
Q1 		– Sell
-194
Closed -$7K – 2791
2015
Q4 		$7K Buy
194
+10
+5% +$378 ﹤0.01% 2095
2015
Q3 		$7K Buy
184
+64
+53% +$2.25K ﹤0.01% 2187
2015
Q2 		$3K Buy
120
+3
+3% +$84 ﹤0.01% 2501
2015
Q1 		$3K Buy
+117
New +$3.29K ﹤0.01% 2411
2014
Q3 		– Sell
-21
Closed -$1K – 2513
2014
Q2 		$1K Hold
21
– – ﹤0.01% 2320
2014
Q1 		$1K Hold
21
– – ﹤0.01% 2288
2013
Q4 		$1K Buy
+21
New +$751 ﹤0.01% 2133

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fifth Third Bancorp's MDCO Position: Q3 2017 in Review

Fifth Third Bancorp sold out of Medicines Co (MDCO) in Q3 2017, closing a stake of 650 shares — an estimated $25K sold.

Fifth Third Bancorp first reported a position in MDCO in Q4 2013 and held it in 8 quarters. The position peaked at $25K in Q2 2017. 190 funds tracked by Wall St. Rank hold MDCO as of Q3 2017.

  • Fifth Third Bancorp reported no remaining Medicines Co position as of Q3 2017 after selling out during the quarter.
  • Fifth Third Bancorp sold 650 Medicines Co shares in Q3 2017, an estimated $25K.
  • Fifth Third Bancorp first reported a position in Medicines Co in Q4 2013 and held it in 8 quarters.
  • Fifth Third Bancorp's Medicines Co position peaked at $25K in Q2 2017.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q3 2017.

Based on Fifth Third Bancorp's 13F filing for Q3 2017, filed 14 Nov 2017.